Risk factors for lymph node metastasis and the impact of adjuvant chemotherapy on ductal carcinoma in situ with microinvasion: a population-based study

BACKGROUND: Ductal carcinoma in situ with microinvasion (DCISM) represents ~1% of all breast cancer cases. Risk factors for lymph node (LN) metastasis and appropriate adjuvant therapy for DCISM are still widely debated. METHODS: We retrieved DCISM data from the National Cancer Institute’s Surveillan...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cong, Huang, Shumin, Huang, Aihua, Jia, Yunlu, Wang, Ji, Zhang, Zeqin, Mao, Misha, Wang, Linbo, Zhou, Jichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300372/
https://www.ncbi.nlm.nih.gov/pubmed/30588019
http://dx.doi.org/10.2147/OTT.S186228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300372/
https://www.ncbi.nlm.nih.gov/pubmed/30588019
http://dx.doi.org/10.2147/OTT.S186228

Ejemplares similares